The raw feed
Latest filings
Every transaction from every Form 4, as filed, newest first. Open-market buys (P) and sells (S) become signals; the rest is shown for completeness.
| Date | Company | Insider | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|---|
| Jan 20, 2023 | GFF GRIFFON CORP | Travis W. Cocke director, other | XIn-the-money exercise Call Option (right to buy)derivativeindirect: By: Voss Value-Oriented Special Situations Fund, L.P. | -16 | $0.00 | $0 | 0 | Jan 24, 2023 |
| Jan 20, 2023 | GFF GRIFFON CORP | Travis W. Cocke director, other | XIn-the-money exercise Call Option (right to buy)derivativeindirect: By: Voss Value-Oriented Special Situations Fund, L.P. | -8 | $0.00 | $0 | 0 | Jan 24, 2023 |
| Jan 20, 2023 | GFF GRIFFON CORP | Travis W. Cocke director, other | XIn-the-money exercise Call Option (right to buy)derivativeindirect: By: Voss Value-Oriented Special Situations Fund, L.P. | -12 | $0.00 | $0 | 0 | Jan 24, 2023 |
| Jan 20, 2023 | GFF GRIFFON CORP | Travis W. Cocke director, other | XIn-the-money exercise Call Option (right to buy)derivativeindirect: By: Managed Accounts of Voss Capital, LLC | -9 | $0.00 | $0 | 0 | Jan 24, 2023 |
| Jan 20, 2023 | GFF GRIFFON CORP | Travis W. Cocke director, other | XIn-the-money exercise Call Option (right to buy)derivativeindirect: By: Managed Accounts of Voss Capital, LLC | -37 | $0.00 | $0 | 0 | Jan 24, 2023 |
| Jan 20, 2023 | GFF GRIFFON CORP | Travis W. Cocke director, other | XIn-the-money exercise Call Option (right to buy)derivativeindirect: By: Managed Accounts of Voss Capital, LLC | -32 | $0.00 | $0 | 0 | Jan 24, 2023 |
| Jan 20, 2023 | GFF GRIFFON CORP | Travis W. Cocke director, other | XIn-the-money exercise Call Option (right to buy)derivativeindirect: By: Managed Accounts of Voss Capital, LLC | -89 | $0.00 | $0 | 0 | Jan 24, 2023 |
| Jan 20, 2023 | GFF GRIFFON CORP | Travis W. Cocke director, other | XIn-the-money exercise Call Option (right to buy)derivativeindirect: By: Managed Accounts of Voss Capital, LLC | -9 | $0.00 | $0 | 0 | Jan 24, 2023 |
| Jan 20, 2023 | GFF GRIFFON CORP | Travis W. Cocke director, other | XIn-the-money exercise Call Option (right to buy)derivativeindirect: By: Managed Accounts of Voss Capital, LLC | -118 | $0.00 | $0 | 0 | Jan 24, 2023 |
| Jan 20, 2023 | GFF GRIFFON CORP | Travis W. Cocke director, other | XIn-the-money exercise Call Option (right to buy)derivativeindirect: By: Managed Accounts of Voss Capital, LLC | -92 | $0.00 | $0 | 0 | Jan 24, 2023 |
| Jan 20, 2023 | GFF GRIFFON CORP | Travis W. Cocke director, other | XIn-the-money exercise Call Option (right to buy)derivativeindirect: By: Managed Accounts of Voss Capital, LLC | -9 | $0.00 | $0 | 0 | Jan 24, 2023 |
| Jan 20, 2023 | GFF GRIFFON CORP | Travis W. Cocke director, other | XIn-the-money exercise Call Option (right to buy)derivativeindirect: By: Managed Accounts of Voss Capital, LLC | -18 | $0.00 | $0 | 0 | Jan 24, 2023 |
| Jan 20, 2023 | GFF GRIFFON CORP | Travis W. Cocke director, other | XIn-the-money exercise Call Option (right to buy)derivativeindirect: By: Managed Accounts of Voss Capital, LLC | -52 | $0.00 | $0 | 0 | Jan 24, 2023 |
| Jan 20, 2023 | GFF GRIFFON CORP | Travis W. Cocke director, other | XIn-the-money exercise Call Option (right to buy)derivativeindirect: By: Managed Accounts of Voss Capital, LLC | -26 | $0.00 | $0 | 0 | Jan 24, 2023 |
| Jan 20, 2023 | GFF GRIFFON CORP | Travis W. Cocke director, other | XIn-the-money exercise Call Option (right to buy)derivativeindirect: By: Managed Accounts of Voss Capital, LLC | -26 | $0.00 | $0 | 0 | Jan 24, 2023 |
| Jan 20, 2023 | GFF GRIFFON CORP | Travis W. Cocke director, other | XIn-the-money exercise Call Option (right to buy)derivativeindirect: By: Managed Accounts of Voss Capital, LLC | -9 | $0.00 | $0 | 0 | Jan 24, 2023 |
| Jan 13, 2023 | MLAB MESA LABORATORIES INC /CO/ | John Bradley Schmieder director | XIn-the-money exercise Common Stock | +571 | $72.02 | $41k | 69,547 | Jan 17, 2023 |
| Jan 13, 2013 | MLAB MESA LABORATORIES INC /CO/ | John Bradley Schmieder director | XIn-the-money exercise Common Stock | +1,000 | $122.66 | $123k | 70,547 | Jan 17, 2023 |
| Jan 13, 2023 | MLAB MESA LABORATORIES INC /CO/ | John Bradley Schmieder director | XIn-the-money exercise Non Qualified Stock Optionsderivative | -571 | $0.00 | $0 | 1,450 | Jan 17, 2023 |
| Jan 13, 2023 | MLAB MESA LABORATORIES INC /CO/ | John Bradley Schmieder director | XIn-the-money exercise Non Qualified Stock Optionderivative | -1,000 | $0.00 | $0 | 450 | Jan 17, 2023 |
| Dec 12, 2022 | INRD Inrad Optics, Inc. | Dennis G Romano director | XIn-the-money exercise Stock Optionderivative | +5,000 | $0.00 | $0 | 80,000 | Jan 17, 2023 |
| Jan 4, 2023 | IRD Ocuphire Pharma, Inc. | Cam Gallagher director | XIn-the-money exercise Common Stock | +1,574 | $0.00 | $0 | 24,928 | Jan 6, 2023 |
| Jan 4, 2023 | IRD Ocuphire Pharma, Inc. | Cam Gallagher director | XIn-the-money exercise Series B Warrant (right to buy)derivative | -1,574 | $0.00 | $0 | 0 | Jan 6, 2023 |
| Jan 4, 2023 | EP EMPIRE PETROLEUM CORP | Thomas W. Pritchard Chief Executive Officer | XIn-the-money exercise Common Stock | +312,918 | $1.32 | $413k | 601,968 | Jan 6, 2023 |
| Jan 4, 2023 | EP EMPIRE PETROLEUM CORP | Thomas W. Pritchard Chief Executive Officer | XIn-the-money exercise Common Stock | +31,472 | $1.40 | $44k | 633,440 | Jan 6, 2023 |
| Dec 28, 2022 | - Sixth Street Lending Partners | Institution for Social Security Public owner | XIn-the-money exercise Common shares of beneficial interest, par value $0.001 | +739,177 | $25.02 | $18M | 4,324,662 | Dec 30, 2022 |
| Dec 28, 2022 | - Sixth Street Lending Partners | Institution for Social Security Public owner | XIn-the-money exercise Obligation to Buyderivative | -739,177 | - | - | 0 | Dec 30, 2022 |
| Dec 28, 2022 | BWB Bridgewater Bancshares Inc | Jeffrey D. Shellberg EVP AND CHIEF CREDIT OFFICER | XIn-the-money exercise Option to buyderivative | -25,000 | $0.00 | $0 | 50,000 | Dec 29, 2022 |
| Dec 23, 2022 | BWB Bridgewater Bancshares Inc | Jerry J. Baack PRESIDENT & CEO | XIn-the-money exercise Option to buyderivative | -30,000 | $0.00 | $0 | 35,000 | Dec 27, 2022 |
| Dec 23, 2022 | BWB Bridgewater Bancshares Inc | Joseph M. Chybowski CHIEF FINANCIAL OFFICER | XIn-the-money exercise Option to buyderivative | -6,000 | $0.00 | $0 | 0 | Dec 27, 2022 |
| Dec 2, 2022 | SRNE Sorrento Therapeutics, Inc. | Henry Ji See Remarks | XIn-the-money exercise Common Stockindirect: By BioVintage, Inc. | +200 | $5.50 | $1,100 | 200 | Dec 23, 2022 |
| Dec 21, 2022 | SRNE Sorrento Therapeutics, Inc. | Henry Ji See Remarks | XIn-the-money exercise Common Stockindirect: By BioVintage, Inc. | +300 | $5.50 | $1,650 | 500 | Dec 23, 2022 |
| Dec 2, 2022 | SRNE Sorrento Therapeutics, Inc. | Henry Ji See Remarks | XIn-the-money exercise Put Option (obligation to buy)derivativeindirect: By BioVintage, Inc. | -2 | $0.00 | $0 | 198 | Dec 23, 2022 |
| Dec 21, 2022 | SRNE Sorrento Therapeutics, Inc. | Henry Ji See Remarks | XIn-the-money exercise Put Option (obligation to buy)derivativeindirect: By BioVintage, Inc. | -3 | $0.00 | $0 | 195 | Dec 23, 2022 |
| Sep 28, 2022 | - Sixth Street Lending Partners | Institution for Social Security Public owner | XIn-the-money exercise Common shares of beneficial interest, par value $0.001 | +1,321,844 | $24.66 | $33M | 2,088,311 | Dec 22, 2022 |
| Oct 27, 2022 | - Sixth Street Lending Partners | Institution for Social Security Public owner | XIn-the-money exercise Common shares of beneficial interest, par value $0.001 | +1,193,313 | $24.61 | $29M | 3,281,624 | Dec 22, 2022 |
| Dec 13, 2022 | - Sixth Street Lending Partners | Institution for Social Security Public owner | XIn-the-money exercise Common shares of beneficial interest, par value $0.001 | +303,861 | $24.99 | $7.6M | 3,585,485 | Dec 22, 2022 |
| Sep 28, 2022 | - Sixth Street Lending Partners | Institution for Social Security Public owner | XIn-the-money exercise Obligation to Buyderivative | -1,321,844 | - | - | 0 | Dec 22, 2022 |
| Oct 27, 2022 | - Sixth Street Lending Partners | Institution for Social Security Public owner | XIn-the-money exercise Obligation to Buyderivative | -1,193,313 | - | - | 0 | Dec 22, 2022 |
| Dec 13, 2022 | - Sixth Street Lending Partners | Institution for Social Security Public owner | XIn-the-money exercise Obligation to Buyderivative | -303,861 | - | - | 0 | Dec 22, 2022 |
| Dec 16, 2022 | ORKA ARCA biopharma, Inc. | Jacob Ma-Weaver director, owner, other | XIn-the-money exercise Common Stock | +1,420,000 | $2.50 | $3.5M | 4,000,452 | Dec 19, 2022 |
| Dec 16, 2022 | ORKA ARCA biopharma, Inc. | Jacob Ma-Weaver director, owner, other | XIn-the-money exercise Put Optionderivative | -14,200 | $0.00 | $0 | 30,000 | Dec 19, 2022 |
| Nov 30, 2022 | NNMX NANOMIX Corp | David Ludvigson Interim CFO | XIn-the-money exercise Common Stock | +42,195 | $0.06 | $2,447 | 1,695,176 | Dec 16, 2022 |
| Nov 30, 2022 | NNMX NANOMIX Corp | David Ludvigson Interim CFO | XIn-the-money exercise Incentive Stock Option (right to buy)derivative | -42,195 | $0.00 | $0 | 1,695,176 | Dec 16, 2022 |
| Dec 14, 2022 | ASLE AerSale Corp | Nicolas Finazzo See Remarks | XIn-the-money exercise Common Stockindirect: See footnote | +58,597 | $10.00 | $586k | 4,190,846 | Dec 16, 2022 |
| Dec 14, 2022 | ASLE AerSale Corp | Nicolas Finazzo See Remarks | XIn-the-money exercise Stock Option (right to buy)derivativeindirect: See footnote | -58,597 | $0.00 | $0 | 0 | Dec 16, 2022 |
| Dec 14, 2022 | ASLE AerSale Corp | Robert B. Nichols See Remarks | XIn-the-money exercise Common Stockindirect: See footnote | +58,597 | $10.00 | $586k | 3,637,483 | Dec 16, 2022 |
| Dec 14, 2022 | ASLE AerSale Corp | Robert B. Nichols See Remarks | XIn-the-money exercise Stock Option (right to buy)derivativeindirect: See footnote | -58,597 | $0.00 | $0 | 0 | Dec 16, 2022 |
| Dec 14, 2022 | ARTNA ARTESIAN RESOURCES CORP | Dian C Taylor C.E.O. President | XIn-the-money exercise Class A Non-voting Common Stock | +1,019 | $21.86 | $22k | 106,040 | Dec 15, 2022 |
| Dec 14, 2022 | ARTNA ARTESIAN RESOURCES CORP | Dian C Taylor C.E.O. President | XIn-the-money exercise Non-qualified Stock Option (Right to Buy)derivative | -1,019 | $0.00 | $0 | 0 | Dec 15, 2022 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.